Parenteral calcitriol for treatment of severe renal osteodystrophy in children with chronic renal insufficiency
- 1 June 1987
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 110 (6) , 966-970
- https://doi.org/10.1016/s0022-3476(87)80426-2
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984
- Circulating calcitriol concentrations in health and diseaseThe Journal of Pediatrics, 1983
- Prevention of phosphate-induced progression of uremia in rats by 3-phosphocitric acidKidney International, 1982
- IS 1,25‐DIHYDROXY‐CHOLECALCIFEROL HARMFUL TO RENAL FUNCTION IN PATIENTS WITH CHRONIC RENAL FAILURE?Clinical Endocrinology, 1981
- Early diagnosis of juvenile renal osteodystrophyThe Journal of Pediatrics, 1980
- Renal osteodystrophyKidney International, 1980
- Childhood renal osteodystrophyKidney International, 1978
- Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol.Journal of Clinical Investigation, 1975
- Metabolism of bovine parathyroid hormone. Immunological and biological characteristics of fragments generated by liver perfusion.Journal of Clinical Investigation, 1975
- Renal osteodystrophy in children: The effect of hemodialysis and renal homotransplantationThe Journal of Pediatrics, 1972